- Trials with a EudraCT protocol (336)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (58)
336 result(s) found for: Irradiation.
Displaying page 1 of 17.
EudraCT Number: 2014-004296-22 | Sponsor Protocol Number: 2014-RdC-PRO-Th | Start Date*: 2015-11-10 | |||||||||||
Sponsor Name:Centre Eugène Marquis | |||||||||||||
Full Title: Anticholinergics impact in the treatment of acute irritative urinary toxicity during radiotherapy for prostate cancer | |||||||||||||
Medical condition: Symptomatology related to acute urinary toxicity occuring during prostate irradiation in patients suffering from prostate cancer. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000614-38 | Sponsor Protocol Number: MW010 | Start Date*: 2013-09-16 |
Sponsor Name:Dr. Willmar Schwabe GmbH & Co. KG | ||
Full Title: Monocenter, prospective, randomized placebo-controlled, double blind phase II trial to evaluate protective effects of Gingko biloba extract EGb 761® on temporary hearing damage caused by noise. | ||
Medical condition: Noise induced hearing impairment (temporarily) | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-002531-83 | Sponsor Protocol Number: IC2007-01 | Start Date*: 2007-10-10 | |||||||||||
Sponsor Name:Institut Curie | |||||||||||||
Full Title: Etude de phase 2 randomisée comparant une irradiation encéphalique associée au témozolomide à une irradiation seule chez des patientes présentant des métastases cérébrales d'un cancer du sein. | |||||||||||||
Medical condition: Patientes présentant des métastases cérébrales d'un cancer du sein, non opérables ou refus de chirurgie. Age > 18 ans. OMS ≤ 2. Pas d’antécédent d’irradiation encéphalique. Le délai entre la fi... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005219-98 | Sponsor Protocol Number: PH3-01 | Start Date*: 2012-10-08 | |||||||||||
Sponsor Name:Galena Biopharma, Inc | |||||||||||||
Full Title: Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax™ Treatment (PRESENT) | |||||||||||||
Medical condition: Operable early-stage, node-positive breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: BG (Prematurely Ended) HU (Prematurely Ended) CZ (Prematurely Ended) DE (Prematurely Ended) GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-018072-33 | Sponsor Protocol Number: UKM08_0057 | Start Date*: 2011-08-01 | ||||||||||||||||
Sponsor Name:Universitätsklinikum Münster | ||||||||||||||||||
Full Title: Prospective Trial for the diagnosis and treatment of children, adolescents and young adults with Intracranial Germ Cell Tumours | ||||||||||||||||||
Medical condition: Intracranial Germ Cell tumours of any histology and intracranial site and dissemination | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) SE (Completed) GB (Completed) FR (Completed) AT (Completed) IT (Ongoing) BE (Ongoing) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-004053-91 | Sponsor Protocol Number: CO19/121741 | Start Date*: 2020-07-06 | |||||||||||
Sponsor Name:University of Leeds | |||||||||||||
Full Title: Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma | |||||||||||||
Medical condition: Recurrent Glioblastoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002985-70 | Sponsor Protocol Number: MD-R20080507 | Start Date*: 2009-04-23 |
Sponsor Name:University of Magdeburg | ||
Full Title: Evaluation of the preventive effect of pentoxifylline and ursodeoxycholic acid to radiation induced liver toxicity after brachytherapy of liver metastases, assessed in a prospective randomised trial. | ||
Medical condition: Irradiation damage to the liver after HDR-brachytherapy of liver metastases. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-004280-22 | Sponsor Protocol Number: RECET | Start Date*: 2010-07-23 | |||||||||||
Sponsor Name:Universitätsklinikum Schleswig-Holstein, Campus Lübeck: Klinik für Strahlentherapie | |||||||||||||
Full Title: Re-irradiation combined with cetuximab for the treatment of patients with locally recurrent or with secondary squamous cell carcinoma of the head and neck | |||||||||||||
Medical condition: Preirradiated patients with locally recurrent or with secondary squamous cell carcinoma of the head and neck | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-005194-27 | Sponsor Protocol Number: 240672 | Start Date*: 2005-03-09 |
Sponsor Name:Department of Neurology, Medical University of Vienna | ||
Full Title: Anti-inflammatory and/or antinociceptive effects of botulinum toxin A in an experimental inflammatory human skin pain model: a randomised, double blinded, placebo controlled study | ||
Medical condition: not applicable In this trial a potential antinociceptive potency af the IMP (Dysport) will be testet i9n a human inflammatory pain model. The present study will only include heathy volunteers. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2015-002185-23 | Sponsor Protocol Number: DIPG | Start Date*: 2015-07-29 | |||||||||||
Sponsor Name:FONDAZIONE IRCCS "ISTITUTO NAZIONALE DEI TUMORI" | |||||||||||||
Full Title: Phase 2 open label randomized study of radiotherapy, concomitant nimotuzumab and vinorelbine and re-irradiation at relapse versus radiotherapy and multiple elective radiotherapy courses with concom... | |||||||||||||
Medical condition: diffuse intrinsic pontine glioma | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003512-27 | Sponsor Protocol Number: AIO-YMO/TRK-0120 | Start Date*: 2021-12-08 | ||||||||||||||||||||||||||
Sponsor Name:AIO-Studien-gGmbH | ||||||||||||||||||||||||||||
Full Title: Radiation during Osimertinib Treatment: a Safety and Efficacy Cohort Study | ||||||||||||||||||||||||||||
Medical condition: Patients with EGFR-mutation positive NSCLC The target population will comprise 3 parallel cohorts, for each of which a minimum of 10 subjects is planned to be enrolled: 1. Irradiation of bone, sol... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013406-13 | Sponsor Protocol Number: GBM-DC-2009 | Start Date*: 2009-10-07 |
Sponsor Name:Masaryk University | ||
Full Title: First Line Therapy of Glioblastoma Multiforme with Surgical Resection, Irradiation Therapy, Temozolomide and Additional Tumour-Lysate Pulsed Dendritic Cell Vaccination. A Feasibility Phase II Study... | ||
Medical condition: Glioblastoma Multiforme | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000133-31 | Sponsor Protocol Number: AGO/2017/001 | Start Date*: 2017-07-31 |
Sponsor Name:UZ Gent | ||
Full Title: Combined hypofractionated stereotactic body radiotherapy with immunomodulating systemic therapy for inoperable recurrent head and neck cancer: detection of the maximum tolerated dose. | ||
Medical condition: local, regional or combined locoregional recurrence of squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx or larynx in previously irradiated tissue, with former irradiation with cu... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-010004-28 | Sponsor Protocol Number: ACNS0331 | Start Date*: 2010-04-14 | ||||||||||||||||
Sponsor Name:COG | ||||||||||||||||||
Full Title: ACNS0331 A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children with Newly Diagnosed Standard Risk Medulloblas... | ||||||||||||||||||
Medical condition: Medulloblastoom standard risk | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006099-39 | Sponsor Protocol Number: DE 0206 | Start Date*: 2006-12-14 |
Sponsor Name:Department of Endocrinology University of Debrecen Medical and Health Science Center | ||
Full Title: Anti-CD20 antitest alkalmazása súlyos, hagyományos kezelésekre nem reagáló endokrin orbitopátiában | ||
Medical condition: Endocrin ophthalmopathy (conventional therapy resistent). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005194-32 | Sponsor Protocol Number: CRANIAL | Start Date*: 2013-06-28 | ||||||||||||||||
Sponsor Name:Institut Jules Bordet | ||||||||||||||||||
Full Title: A phase II trial evaluating Cabazitaxel in patients with brain metastasis secondary to breast and non-small-cell lung cancer | ||||||||||||||||||
Medical condition: Brain metastasis secondary to HER2-negative breast cancer and NSCLC, not previously irradiated and not requiring immediate radiation. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-008921-30 | Sponsor Protocol Number: 09.02 | Start Date*: 2009-03-17 | |||||||||||
Sponsor Name:Odense University Hospital | |||||||||||||
Full Title: Concomitant Tarceva® and irradiation in patients in local-regionally advanced non-small cell lung cancer. A phase II study | |||||||||||||
Medical condition: Local-regionally advanced non-small cell lung cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004524-36 | Sponsor Protocol Number: FESB-DE-310 | Start Date*: 2006-10-24 | |||||||||||
Sponsor Name:Novartis Consumer Health SA | |||||||||||||
Full Title: A randomized, double-blind, vehicle controlled, single center, intra-individual comparative study of the efficacy and safety of diclofenac sodium 1 mg/g (0.1%) gel in subjects with painful UV-induc... | |||||||||||||
Medical condition: Relief of pain and erythema associated with superficial sunburn | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002548-12 | Sponsor Protocol Number: TJB0702 | Start Date*: 2007-12-17 | |||||||||||
Sponsor Name:CHU-ULG | |||||||||||||
Full Title: Allogeneic hematopoietic cell transplantation with HLA-matched donors : a phase II randomized study comparing 2 nonmyeloablative conditionings | |||||||||||||
Medical condition: Patients with hematological malignancies not candidate for conventional allogeneic transplantation because of age or comorbidities | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-005247-10 | Sponsor Protocol Number: ITCC-003-Tarceva/Roche MO 18461 | Start Date*: 2005-07-29 |
Sponsor Name:The University Hospitals of Leicester NHS Trust | ||
Full Title: Phase I study of TARCEVA (Erlotinib Hydrochloride, OSI-774) as a single agent in children with refractory and relapsed malignant brain tumours and in combination with irradiation in newly diagnosed... | ||
Medical condition: Refractory and relapsed malignant brain tumours and newly diagnosed brain stem glioma. | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) IT (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.